30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Zogenix Inc (ZGNX)

Track

Stock chart
Ticker: ZGNX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
MAST ERLE T
1 sale — total 32,545 USD
Planned sale 1 Feb 2022
Value US$4,328,843.82 | Price 40.86 | Shares 56,170
Planned sale 19 Jan 2022
Value US$1,462,673.00 | Price 73.80 | Shares 92,289
Sale 29 Nov 2021
Value US$62,174.60 | Price 11.72 | Shares 5,305
Buy 1 Jun 2021
Value US$9,968.88 | Price 17.07 | Shares 584
Buy 1 Jun 2021
Value US$85,247.50 | Price 17.05 | Shares 5,000
Buy 10 May 2021
Value US$285,496.50 | Price 19.03 | Shares 15,000
Buy 19 Nov 2020
Value US$161,041.60 | Price 20.13 | Shares 8,000
Sale 17 Nov 2020
Value US$311,065.50 | Price 20.74 | Shares 15,000
Planned sale 12 May 2020
Value US$72,584.33 | Price 28.21 | Shares 2,573
Buy 8 May 2020
Value US$25,450.00 | Price 25.45 | Shares 1,000
Buy 23 Mar 2020
Value US$51,196.00 | Price 20.48 | Shares 2,500
Planned sale 19 Mar 2020
Value US$113,963.64 | Price 18.51 | Shares 6,158
Buy 18 Mar 2020
Value US$19,685.00 | Price 19.69 | Shares 1,000
Buy 13 Mar 2020
Value US$174,647.20 | Price 21.83 | Shares 8,000
Planned sale 8 Jan 2020
Value US$275,105.07 | Price 52.20 | Shares 5,270
Planned sale 8 Jan 2020
Value US$1,500,815.83 | Price 51.83 | Shares 28,955
Planned sale 2 Jan 2020
Value US$393,277.24 | Price 52.09 | Shares 7,550
Planned sale 2 Jan 2020
Value US$772,062.85 | Price 51.64 | Shares 14,950
Planned sale 16 Dec 2019
Value US$250,000.00 | Price 50.00 | Shares 5,000
Planned sale 25 Nov 2019
Value US$250,000.00 | Price 50.00 | Shares 5,000
Planned sale 25 Nov 2019
Value US$1,711,250.00 | Price 50.00 | Shares 34,225
Planned sale 25 Nov 2019
Value US$720,000.00 | Price 48.00 | Shares 15,000
Planned sale 22 Aug 2019
Value US$179,192.00 | Price 52.00 | Shares 3,446
Planned sale 9 Aug 2019
Value US$750,000.00 | Price 50.00 | Shares 15,000
Planned sale 9 Aug 2019
Value US$312,500.00 | Price 50.00 | Shares 6,250
Planned sale 3 Jul 2019
Value US$957,093.15 | Price 48.16 | Shares 19,872
Planned sale 3 Jul 2019
Value US$686,067.66 | Price 47.80 | Shares 14,353
Planned sale 27 Jun 2019
Value US$694,800.00 | Price 46.32 | Shares 15,000
Planned sale 29 Mar 2019
Value US$863,500.00 | Price 55.00 | Shares 15,700
Planned sale 29 Mar 2019
Value US$275,000.00 | Price 55.00 | Shares 5,000
Sale 14 Mar 2019
Value US$2,053,260.80 | Price 52.93 | Shares 38,789
Sale 13 Mar 2019
Value US$1,126,215.01 | Price 53.10 | Shares 21,211
Sale 6 Mar 2019
Value US$886,474.44 | Price 50.65 | Shares 17,503
Planned sale 1 Mar 2019
Value US$215,000.00 | Price 50.00 | Shares 4,300
Planned sale 1 Mar 2019
Value US$762,500.00 | Price 50.00 | Shares 15,250
Planned sale 27 Feb 2019
Value US$43,450.00 | Price 50.00 | Shares 869
Planned sale 26 Feb 2019
Value US$237,800.00 | Price 50.00 | Shares 4,756
Planned sale 12 Feb 2019
Value US$581,146.96 | Price 46.85 | Shares 12,405
Planned sale 10 Jan 2019
Value US$2,475,000.00 | Price 45.00 | Shares 55,000
Planned sale 10 Jan 2019
Value US$1,575,045.00 | Price 45.00 | Shares 35,001
Planned sale 10 Jan 2019
Value US$14,040.00 | Price 45.00 | Shares 312
Sale 14 Dec 2018
Value US$826,910.00 | Price 41.35 | Shares 20,000
Sale 26 Nov 2018
Value US$61,772.27 | Price 42.08 | Shares 1,468
Planned sale 4 Oct 2018
Value US$85,765.51 | Price 43.74 | Shares 1,961
Planned sale 4 Oct 2018
Value US$125,025.67 | Price 43.11 | Shares 2,900
Planned sale 4 Oct 2018
Value US$90,137.04 | Price 42.92 | Shares 2,100
Planned sale 4 Sep 2018
Value US$110,872.42 | Price 48.21 | Shares 2,300
Planned sale 4 Sep 2018
Value US$222,169.94 | Price 47.27 | Shares 4,700
Buy 10 Aug 2018
Value US$5,200,000.00 | Price 52.00 | Shares 100,000
Planned sale 8 Aug 2018
Value US$100,995.07 | Price 53.16 | Shares 1,900
Planned sale 8 Aug 2018
Value US$267,317.52 | Price 52.42 | Shares 5,100
Planned sale 12 Jun 2018
Value US$230,310.00 | Price 45.00 | Shares 5,118
Sale 16 May 2018
Value US$8,698.20 | Price 39.90 | Shares 218
Sale 13 Mar 2018
Value US$1,239,436.81 | Price 44.65 | Shares 27,760
Sale 12 Mar 2018
Value US$1,108,134.45 | Price 44.83 | Shares 24,716
Sale 12 Mar 2018
Value US$325,549.50 | Price 44.97 | Shares 7,240
Planned buy 13 Dec 2017
Value US$49,244.62 | Price 36.59 | Shares 1,346
Sale 11 Dec 2017
Value US$368,407.00 | Price 36.84 | Shares 10,000
Sale 11 Dec 2017
Value US$311,746.00 | Price 36.84 | Shares 8,462
Sale 11 Dec 2017
Value US$1,648,289.76 | Price 36.84 | Shares 44,741
Sale 8 Dec 2017
Value US$436,703.71 | Price 37.02 | Shares 11,797
Sale 7 Dec 2017
Value US$728,000.00 | Price 36.40 | Shares 20,000
Sale 7 Dec 2017
Value US$327,600.00 | Price 36.40 | Shares 9,000
Sale 7 Dec 2017
Value US$450,268.00 | Price 36.40 | Shares 12,370
Sale 7 Dec 2017
Value US$553,744.50 | Price 36.92 | Shares 15,000
Buy 3 Oct 2017
Value US$11,250,000.00 | Price 37.50 | Shares 300,000
Buy 29 Sep 2017
Value US$610,341.25 | Price 27.67 | Shares 22,055
Buy 29 Sep 2017
Value US$358,080.91 | Price 40.14 | Shares 8,920
Buy 29 Sep 2017
Value US$493,600.27 | Price 39.22 | Shares 12,586
Buy 29 Sep 2017
Value US$312,791.42 | Price 38.56 | Shares 8,112
Buy 29 Sep 2017
Value US$228,529.80 | Price 37.14 | Shares 6,153
Buy 29 Sep 2017
Value US$137,805.10 | Price 36.26 | Shares 3,800
Buy 29 Sep 2017
Value US$209,475.00 | Price 34.91 | Shares 6,000
Buy 29 Sep 2017
Value US$279,664.60 | Price 33.86 | Shares 8,260
Buy 29 Sep 2017
Value US$525,310.61 | Price 32.96 | Shares 15,937
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-02-03 2022-02-01 PlS Planned sale
MAST ERLE T
Non-Executive Director
56,170 -6.2%
40.86
US$4,328,844 		56,170 -6.2% 40.86 US$4,328,844
2022-01-21 2022-01-19 PlS Planned sale
MAST ERLE T
Non-Executive Director
92,289 +36.8%
73.80
US$1,462,673 		92,289 +36.8% 73.80 US$1,462,673
2021-11-30 2021-11-29 S Sale
3.4
TANNENBAUM RENEE P
Non-Executive Director
74,264 -40.3%
151.63
US$2,877,299 		74,264 -40.3% 151.63 US$2,877,299
2021-06-03 2021-06-01 B Purchase
Waynick Denelle J
Non-Executive Director
584 +inf%
17.07
US$9,969 		584 +inf% 17.07 US$9,969
2021-06-03 2021-06-01 B Purchase
3.4
TANNENBAUM RENEE P
Non-Executive Director
5,000 +15.2%
17.05
US$85,248 		5,000 +15.2% 17.05 US$85,248
2021-05-12 2021-05-10 B Purchase
GARNER CAM L
Non-Executive Director
15,000 +93.8%
19.03
US$285,496 		15,000 +93.8% 19.03 US$285,496
2020-11-20 2020-11-19 B Purchase
GARNER CAM L
Non-Executive Director
8,000 +100.0%
20.13
US$161,042 		8,000 +100.0% 20.13 US$161,042
2020-11-18 2020-11-17 S Sale
3.4
TANNENBAUM RENEE P
Non-Executive Director
15,000 -31.3%
20.74
US$311,066 		15,000 -31.3% 20.74 US$311,066
2020-05-13 2020-05-12 PlS Planned sale
3.7
Farfel Gail M

EVP/Chief Development Officer

Officer
2,573 -33.8%
28.21
US$72,584 		2,573 -33.8% 28.21 US$72,584
2020-05-11 2020-05-08 B Purchase
Sagrolikar Ashish M

EVP & CHIEF COMMERCIAL OFFICER

Officer
1,000 +20.4%
25.45
US$25,450 		1,000 +20.4% 25.45 US$25,450
2020-03-24 2020-03-23 B Purchase
1.0
WIGGINS MARK C
Non-Executive Director
2,500 +inf%
20.48
US$51,196 		2,500 +inf% 20.48 US$51,196
2020-03-20 2020-03-19 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
6,158 -10.0%
18.51
US$113,964 		6,158 -10.0% 18.51 US$113,964
2020-03-20 2020-03-18 B Purchase
Galer Bradley S.

EVP/Chief Medical Officer

Officer
1,000 +11.1%
19.69
US$19,685 		1,000 +11.1% 19.69 US$19,685
2020-03-18 2020-03-13 B Purchase
GARNER CAM L
Non-Executive Director
8,000 +inf%
21.83
US$174,647 		8,000 +inf% 21.83 US$174,647
2020-01-10 2020-01-08 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
5,270 -8.5%
52.20
US$275,105 		5,270 -8.5% 52.20 US$275,105
2020-01-10 2020-01-08 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
28,955 -31.8%
51.83
US$1,500,816 		28,955 -31.8% 51.83 US$1,500,816
2020-01-03 2020-01-02 PlS Planned sale
Smith Michael P

EVP, CFO, Treasurer & Sec.
7,550 -84.5%
52.09
US$393,277 		7,550 -84.5% 52.09 US$393,277
2020-01-03 2020-01-02 PlS Planned sale
Smith Michael P

EVP, CFO, Treasurer & Sec.
14,950 -62.6%
51.64
US$772,063 		14,950 -62.6% 51.64 US$772,063
2019-12-18 2019-12-16 PlS Planned sale BREITMEYER JAMES B Non-Executive Director
5,000 -80.0%
50.00
US$250,000 		5,000 -80.0% 50.00 US$250,000
2019-11-27 2019-11-25 PlS Planned sale
3.0
BREITMEYER JAMES B
5,000 -80.0%
50.00
US$250,000 		5,000 -80.0% 50.00 US$250,000
2019-11-27 2019-11-25 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
34,225 -37.7%
50.00
US$1,711,250 		34,225 -37.7% 50.00 US$1,711,250
2019-11-27 2019-11-25 PlS Planned sale
Smith Michael P

EVP, CFO, Treasurer & Sec.
15,000 -91.5%
48.00
US$720,000 		15,000 -91.5% 48.00 US$720,000
2019-08-23 2019-08-22 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
3,446 -41.3%
52.00
US$179,192 		3,446 -41.3% 52.00 US$179,192
2019-08-12 2019-08-09 PlS Planned sale Smith Michael P

EVP, CFO, Treasurer & Sec.

Officer
15,000 -91.5%
50.00
US$750,000 		15,000 -91.5% 50.00 US$750,000
2019-08-12 2019-08-09 PlS Planned sale WIGGINS MARK C Non-Executive Director
6,250 -100.0%
50.00
US$312,500 		6,250 -100.0% 50.00 US$312,500
2019-07-05 2019-07-03 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
19,872 -26.5%
48.16
US$957,093 		19,872 -26.5% 48.16 US$957,093
2019-07-05 2019-07-03 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
14,353 -16.1%
47.80
US$686,068 		14,353 -16.1% 47.80 US$686,068
2019-07-01 2019-06-27 PlS Planned sale
Smith Michael P

EVP, CFO, Treasurer & Sec.
15,000 -91.5%
46.32
US$694,800 		15,000 -91.5% 46.32 US$694,800
2019-04-02 2019-03-29 PlS Planned sale
0.6
HAWLEY ROGER
15,700 -59.8%
55.00
US$863,500 		15,700 -59.8% 55.00 US$863,500
2019-04-02 2019-03-29 PlS Planned sale
0.6
HAWLEY ROGER
5,000 -32.1%
55.00
US$275,000 		5,000 -32.1% 55.00 US$275,000
2019-03-15 2019-03-14 S Sale
0.6
HAWLEY ROGER
Non-Executive Director
38,789 -78.6%
52.93
US$2,053,261 		38,789 -78.6% 52.93 US$2,053,261
2019-03-15 2019-03-13 S Sale
0.6
HAWLEY ROGER
Non-Executive Director
21,211 -30.1%
53.10
US$1,126,215 		21,211 -30.1% 53.10 US$1,126,215
2019-03-08 2019-03-06 S Sale
3.4
TANNENBAUM RENEE P
17,503 -26.8%
50.65
US$886,474 		17,503 -26.8% 50.65 US$886,474
2019-03-05 2019-03-01 PlS Planned sale
0.6
HAWLEY ROGER
Non-Executive Director
4,300 -5.7%
50.00
US$215,000 		4,300 -5.7% 50.00 US$215,000
2019-03-05 2019-03-01 PlS Planned sale
GARNER CAM L
Non-Executive Director
15,250 -100.0%
50.00
US$762,500 		15,250 -100.0% 50.00 US$762,500
2019-02-28 2019-02-27 PlS Planned sale
GARNER CAM L
Non-Executive Director
869 -100.0%
50.00
US$43,450 		869 -100.0% 50.00 US$43,450
2019-02-28 2019-02-26 PlS Planned sale
GARNER CAM L
Non-Executive Director
4,756 -100.0%
50.00
US$237,800 		4,756 -100.0% 50.00 US$237,800
2019-02-14 2019-02-12 PlS Planned sale
GARNER CAM L
Non-Executive Director
12,405 -100.0%
46.85
US$581,147 		12,405 -100.0% 46.85 US$581,147
2019-01-11 2019-01-10 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
55,000 -51.4%
45.00
US$2,475,000 		55,000 -51.4% 45.00 US$2,475,000
2019-01-11 2019-01-10 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
35,001 -40.3%
45.00
US$1,575,045 		35,001 -40.3% 45.00 US$1,575,045
2019-01-11 2019-01-10 PlS Planned sale
FARR STEPHEN J

President and CEO

Executive Director
312 -0.6%
45.00
US$14,040 		312 -0.6% 45.00 US$14,040
2018-12-17 2018-12-14 S Sale HAWLEY ROGER Non-Executive Director
20,000 -22.1%
41.35
US$826,910 		20,000 -22.1% 41.35 US$826,910
2018-11-26 2018-11-26 S Sale MAST ERLE T Non-Executive Director
1,468 -32.7%
42.08
US$61,772 		1,468 -32.7% 42.08 US$61,772
2018-10-09 2018-10-04 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
1,961 -21.5%
43.74
US$85,766 		1,961 -21.5% 43.74 US$85,766
2018-10-09 2018-10-04 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
2,900 -24.2%
43.11
US$125,026 		2,900 -24.2% 43.11 US$125,026
2018-10-09 2018-10-04 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
2,100 -14.9%
42.92
US$90,137 		2,100 -14.9% 42.92 US$90,137
2018-09-05 2018-09-04 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
2,300 -24.4%
48.21
US$110,872 		2,300 -24.4% 48.21 US$110,872
2018-09-05 2018-09-04 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
4,700 -33.2%
47.27
US$222,170 		4,700 -33.2% 47.27 US$222,170
2018-08-14 2018-08-10 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
100,000 +2.5%
52.00
US$5,200,000 		100,000 +2.5% 52.00 US$5,200,000
2018-08-10 2018-08-08 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
1,900 -21.0%
53.16
US$100,995 		1,900 -21.0% 53.16 US$100,995
2018-08-10 2018-08-08 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
5,100 -36.1%
52.42
US$267,318 		5,100 -36.1% 52.42 US$267,318
2018-06-13 2018-06-12 PlS Planned sale Farfel Gail M

EVP/Chief Development Officer

Officer
5,118 -41.7%
45.00
US$230,310 		5,118 -41.7% 45.00 US$230,310
2018-05-17 2018-05-16 S Sale GARNER CAM L Non-Executive Director
218 -100.0%
39.90
US$8,698 		218 -100.0% 39.90 US$8,698
2018-03-14 2018-03-13 S Sale HAWLEY ROGER
27,760 -23.5%
44.65
US$1,239,437 		27,760 -23.5% 44.65 US$1,239,437
2018-03-14 2018-03-12 S Sale BOCK LOUIS C
24,716 -100.0%
44.83
US$1,108,134 		24,716 -100.0% 44.83 US$1,108,134
2018-03-14 2018-03-12 S Sale HAWLEY ROGER
7,240 -7.4%
44.97
US$325,549 		7,240 -7.4% 44.97 US$325,549
2017-12-15 2017-12-13 PP Planned purchase Galer Bradley S.

EVP/Chief Medical Officer
1,346 +50.1%
36.59
US$49,245 		1,346 +50.1% 36.59 US$49,245
2017-12-11 2017-12-11 S Sale HAWLEY ROGER
10,000 -9.9%
36.84
US$368,407 		10,000 -9.9% 36.84 US$368,407
2017-12-11 2017-12-11 S Sale HAWLEY ROGER
8,462 -8.5%
36.84
US$311,746 		8,462 -8.5% 36.84 US$311,746
2017-12-11 2017-12-11 S Sale HAWLEY ROGER
44,741 -33.1%
36.84
US$1,648,290 		44,741 -33.1% 36.84 US$1,648,290
2017-12-11 2017-12-08 S Sale HAWLEY ROGER
11,797 -11.5%
37.02
US$436,704 		11,797 -11.5% 37.02 US$436,704
2017-12-11 2017-12-07 S Sale HAWLEY ROGER
20,000 -18.1%
36.40
US$728,000 		20,000 -18.1% 36.40 US$728,000
2017-12-11 2017-12-07 S Sale HAWLEY ROGER
9,000 -9.0%
36.40
US$327,600 		9,000 -9.0% 36.40 US$327,600
2017-12-11 2017-12-07 S Sale HAWLEY ROGER
12,370 -12.0%
36.40
US$450,268 		12,370 -12.0% 36.40 US$450,268
2017-12-11 2017-12-07 S Sale HAWLEY ROGER
15,000 -14.2%
36.92
US$553,744 		15,000 -14.2% 36.92 US$553,744
2017-10-03 2017-10-03 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
300,000 +8.2%
37.50
US$11,250,000 		300,000 +8.2% 37.50 US$11,250,000
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
22,055 +0.6%
27.67
US$610,341 		22,055 +0.6% 27.67 US$610,341
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
8,920 +0.2%
40.14
US$358,081 		8,920 +0.2% 40.14 US$358,081
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
12,586 +0.3%
39.22
US$493,600 		12,586 +0.3% 39.22 US$493,600
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
8,112 +0.2%
38.56
US$312,791 		8,112 +0.2% 38.56 US$312,791
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
6,153 +0.2%
37.14
US$228,530 		6,153 +0.2% 37.14 US$228,530
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
3,800 +0.1%
36.26
US$137,805 		3,800 +0.1% 36.26 US$137,805
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
6,000 +0.2%
34.91
US$209,475 		6,000 +0.2% 34.91 US$209,475
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
8,260 +0.2%
33.86
US$279,665 		8,260 +0.2% 33.86 US$279,665
2017-10-03 2017-09-29 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
15,937 +0.4%
32.96
US$525,311 		15,937 +0.4% 32.96 US$525,311
Explore more

More insider trading research around Zogenix Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America